Amedisys Helps Hospital Partner Reduce Heart Failure Readmission Rate by 13%
in One Year
Collaborative Care Leads to a Reduction in Heart Failure Readmissions
BATON ROUGE, La. -- February 20, 2013
Amedisys, Inc. (NASDAQ: AMED), one of the nation’s leading health care at home
companies, released a case study today that highlights how it helped
Monongahela Valley Hospital (MVH) reduce its heart failure readmissions by 13%
in one year through a collaborative care model.
With the implementation of the Affordable Care Act, which includes a
heightened focus on reducing avoidable readmissions, MVH, a community hospital
in western Pennsylvania, wanted to reduce its heart failure readmission rate,
which in 2010 was 27% - nearly 3% higher than the national average.
MVH formed a collaborative including its case management team, an MVH
dietician and pharmacist, the Havencrest skilled nursing facility, the
Residence at the Hilltop personal care home and Amedisys Home Health Care.
Working together, the collaborative began to see a reduction in heart failure
readmissions as early as Q1 2011 – and reduced heart failure readmission rate
by 13% in one year.
“We at Amedisys believe strongly that collaboration with post-acute care
partners including implementation of effective care transitions of patients
from acute care settings back home can help patients better manage their
chronic conditions such as heart failure,” stated Dr. Michael Fleming, Chief
Medical Officer for Amedisys. “The MVH collaborative is proof that post-acute
care is mission critical for reducing avoidable hospital readmission.”
Key learnings from the study include medication reconciliation between
cross-settings is essential; the majority of heart failure patients require
post-hospital intervention in the home; sharing a transfer summary across
settings greatly improves communication; pre-determined standing protocols
across the continuum make an impact; and it takes a community working together
to reduce 30-day readmissions.
To view a case study on how Amedisys helped MVH reduce its heart failure
readmission rate, please click here.
Amedisys, Inc. (NASDAQ: AMED) is a leading health care at home company
delivering personalized home health and hospice care to more than 360,000
patients each year. Amedisys is focused on delivering the care that is best
for our patients, whether that is home-based recovery and rehabilitation after
an operation or injury, care focused on empowering them to manage a chronic
disease, palliative care for those with a terminal illness, or hospice care at
the end of life. The Company's state-of-the-art advanced chronic care
management programs and leading-edge technology enables it to deliver quality
care based upon the latest evidence-based best practices. Amedisys is a
recognized innovator, being one of the first in the industry to equip its
clinicians with point-of-care laptop technology and referring physicians with
an internet portal that enables real-time coordination of patient care
seamlessly. Amedisys also has the industry's first-ever nationwide Care
Transitions program, designed to reduce unnecessary hospital readmissions
through patient and caregiver health coaching and care coordination, which
starts in the hospital and continues throughout completion of the patient's
home health plan of care. For more information about the Company, please
Jacqueline Chen Valencia, 225-252-5091
Marketing & Communications
Press spacebar to pause and continue. Press esc to stop.